Lincoln Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lincoln Pharmaceuticals has submitted a routine quarterly compliance certificate from its Registrar & Share Transfer Agent (RTA), MUFG Intime India Private Limited, for the October–December 2025 quarter. The certificate confirms that all share dematerialisation requests received from depository participants during the quarter were processed (accepted or rejected) within the timelines set by SEBI. Physical share certificates received for demat were mutilated and cancelled, and the depository's name was substituted as the registered owner in the company's member register. This is a standard regulatory disclosure required every quarter under SEBI's depository rules and reflects normal share administration activity.
This is a routine procedural filing with no material impact on the company's business, financials, or stock price. It merely confirms that share transfer and demat operations are running smoothly in compliance with SEBI rules.